Literature DB >> 12167341

Interleukin 17 modulates the immune response to vaccinia virus infection.

Andriani C Patera1, Lesley Pesnicak, John Bertin, Jeffrey I Cohen.   

Abstract

Interleukin 17 (IL-17) is a newly identified cytokine that has a homolog in herpesvirus saimiri. We inserted murine IL-17 into vaccinia virus to study the role of IL-17 in viral infection. Vaccinia virus expressing IL-17 (vv-IL17) and its parental control virus (vv-pRB) grew to similar titers in vitro; however, vv-IL17 was more virulent in mice with a threefold lower LD(50) than for vv-pRB, and mean time to death of 2.8 days versus 4.5 days. Mice infected with vv-IL17 had higher titers of virus in the ovaries (P < 0.02) and showed a decrease in NK cell cytotoxicity (P < 0.02) on day 3 after infection. No significant difference was found in CTL activity. In addition, a significant decrease in IgG2a (P < 0.01) and increases in IgG1, IgG3, and IgA (P < 0.03) vaccinia virus-specific antibody titers were observed in mice infected with vv-IL17 versus vv-pRB, suggesting a Th-2-like response to infection. These data indicate that IL-17 modulates the immune response during virus infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167341     DOI: 10.1006/viro.2002.1400

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

Review 1.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype.

Authors:  Norman Yeh; Nicole L Glosson; Nan Wang; Lynette Guindon; Carl McKinley; Hiromasa Hamada; Qingsheng Li; Richard W Dutton; Protul Shrikant; Baohua Zhou; Randy R Brutkiewicz; Janice S Blum; Mark H Kaplan
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

3.  SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.

Authors:  Neelam Dhiman; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; Megan M O'Byrne; Inna G Ovsyannikova; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2010-03-10       Impact factor: 2.846

4.  Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance.

Authors:  Dhiraj Acharya; Penghua Wang; Amber M Paul; Jianfeng Dai; David Gate; Jordan E Lowery; Dobrivoje S Stokic; A Arturo Leis; Richard A Flavell; Terrence Town; Erol Fikrig; Fengwei Bai
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

Review 6.  Cytokine production associated with smallpox vaccine responses.

Authors:  Whitney L Simon; Hannah M Salk; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

Review 7.  Regulation and function of proinflammatory TH17 cells.

Authors:  Gustavo J Martinez; Roza I Nurieva; Xuexian O Yang; Chen Dong
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.

Authors:  Michiko K Oyoshi; Abdallah Elkhal; Lalit Kumar; Jordan E Scott; Suresh Koduru; Rui He; Donald Y M Leung; Michael D Howell; Hans C Oettgen; George F Murphy; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

Review 9.  Th17 cells in human disease.

Authors:  Laura A Tesmer; Steven K Lundy; Sujata Sarkar; David A Fox
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

10.  Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.

Authors:  Yuko Kawakami; Yoshiaki Tomimori; Kenji Yumoto; Shunji Hasegawa; Tomoaki Ando; Yutaka Tagaya; Shane Crotty; Toshiaki Kawakami
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.